The field of cancer diagnosis and treatment has witnessed significant advancements with the emergence of liquid biopsies, particularly the analysis of circulating cell-free tumor DNA (cfDNA). Circulating cell-free tumor DNA refers to fragments of tumor-derived DNA that circulate in the bloodstream, offering valuable insights into the genomic profile of cancerous tumors. The circulating cell-free tumor DNA market encompasses various aspects, including technology advancements, diagnostic ... Read more
